Southpoint Capital Advisors LP Regeneron Pharmaceuticals, Inc. Transaction History

Southpoint Capital Advisors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$284.6 - $344.99 $22.8 Million - $27.6 Million	-80,000 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $9.47 Million - $11.8 Million	-30,000 Reduced 27.27%	80,000 $27.5 Million
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $14.3 Million - $18.8 Million	40,000 Added 57.14%	110,000 $41.4 Million
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $30.2 Million - $35.3 Million	70,000	70,000 $31.3 Million

1,487

85.7M

1.53M

1.43M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Southpoint Capital Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Southpoint Capital Advisors LP with notifications on news.